Whether you treat patients with transplantable disorders or perform hematopoietic transplantation, this CME-certified program provides an efficient way to hear the latest review in allogeneic transplantation today. In this session, you will learn about the influence of patient and donor factors on unrelated transplant outcomes.
Mary M. Horowitz, M.D., M.S.
Professor of Medicine, Chief Scientific Director
Center for International Blood and Marrow Transplant Research
Medical College of Wisconsin
- Explain why an HLA-mismatched donor may be an option for patients requiring hematopoietic cell transplantation
- Describe the effects of mismatching at various HLA loci
- Understand how differences between equivalently HLA-matched donors affect outcomes in hematopoietic cell transplantation
This activity is intended for physicians and other healthcare providers who treat patients with hematological malignancies in need of allogeneic transplantation.
The goal of this activity is to provide physicians and other healthcare providers with information on the new research that defines when transplantation should be considered, whether the outcomes are different between related and unrelated donors, the current state of HLA matching, and insight into the future of transplantation medicine.
If you have any questions regarding this program, call Renee Ryan at (800) 526-7809 ext. 8430, or e-mail email@example.com